ev3 Inc. to Present at the 2009 Citi Investment Research Small and Mid Cap Conference on November 19, 2009
Nov 12, 2009
To access the webcast, go to the investor relations section of the ev3 Web site at http://ir.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.
About
Since its founding in 2000, ev3 has been dedicated to developing innovative and breakthrough technologies for the endovascular treatment of peripheral vascular and neurovascular diseases. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- plaque excision systems, peripheral angioplasty balloons, stents, embolic protection devices, liquid embolics, embolization coils, flow diversion devices, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.
ev3 and the ev3 logo are trademarks of
CONTACT
Investors and Media
Chief Communications Officer
(949) 680-1375
jtracy@ev3.net